NY-DILIGENT
26.6.2020 15:02:13 CEST | Business Wire | Press release
Diligent Corporation, a leading modern governance company used by nearly 700,000 board directors and leaders, today introduced Modern Leadership – an initiative to provide senior leaders with the resources, insights, partnerships, and technology they need to further catalyze diversity in their organizations and modernize governance.
Diligent also announced today, Diligent Director Network – the largest and most diverse community of board-ready executives globally created to widen the pool of diverse candidates for a vacant board seat. With the Director Network, Diligent is:
- Activating Diligent’s network of nearly 700,000 board directors and leaders across 16,000 organizations to nominate diverse, board-ready executives to build a database of largely untapped talent that will be searchable free of charge within the Diligent application.
- Teaming up with leading private equity firms to post more than 50 board roles for increased visibility and transparency for diverse director candidates. The 10+ private equity firms that have each committed to posting five open board roles include Insight Partners, Clearlake Capital, Vista Equity Partners, Hellman & Friedman, Hg, Genstar Capital, TA Associates, K1 Investment Management, Aurora Capital Partners, and Grain Management.
- Partnering with Spencer Stuart, a leading executive search and leadership advisory firm, to post board searches in the Diligent application creating more transparency for diverse candidates to apply for those roles. Spencer Stuart has long recognized the value of board diversity – last year, minority executives and women comprised more than 60% of their placements in the U.S.
- Partnering with organizations that have a track record and mission for diversifying board rooms and executive suites – including The Executive Leadership Council, Ascend, Latino Corporate Directors Association, and National Association of Corporate Directors – to promote and create opportunities for their members.
- Opening an offer to Diligent’s clients to post open board and executive roles within Director Network for visibility and transparency for diverse rising directors.
“Diligent is committed to being a catalyst for greater diversity and inclusion, starting with the highest levels of leadership – and we are using our network of nearly 700,000 board directors and leaders to help drive that change,” said Brian Stafford, CEO of Diligent. “By increasing the number and visibility of diverse board members, truly changing composition from the top, we believe organizations will be able to better serve stakeholders and create long-lasting, positive change in the world. We hope other companies will join us to create more board and C-Suite opportunities for diverse talent.”
“There is no doubt that successful and visionary corporate leadership today requires diverse viewpoints, perspectives, and experiences that create a richer fabric for guidance and decision making, and Modern Leadership is meant to help organizations create their best futures,” continued Mr. Stafford.
The first job posting in the Director Network is from Diligent itself as the Diligent board of directors seeks to add an additional independent director, ideally with a racially diverse background.
There has never been a more pressing time for change and diversity in the U.S. and across the globe – and a more critical moment to identify and address a lack of diversity within the highest levels of leadership. Today, there are only four Black CEOs across Fortune 500 companies, representing less than 1% of the makeup. Additionally, 83.9% of all directors of Fortune 500 companies are Caucasian/White according to Deloitte. Modern Leadership intends to improve those numbers as Diligent and other companies actively measure and report on diversity as a part of their ESG strategy.
Modern Leadership will also include convenings of existing, rising, and next generation leadership to discuss actions to drive change in the boardroom and at the executive level.
Creating transparency around available board roles via partnerships with private equity
“In order to address social and economic justice, we need scalable solutions that speak to both Main Street and the boardroom,” said Robert F. Smith, Founder, Chairman and CEO of Vista. “We’re proud of the work Vista Equity Partners’ portfolio companies are doing to address access, equality, and building the talent pipeline, and we’re thrilled to also join Diligent's smart and scalable initiative to increase board diversity. This is the right way to empower corporations to make strides towards equality of opportunity. Vista proudly joins Diligent and its partners in taking this critical step along the path toward a more just and equitable future."
“Diligent’s Modern Leadership initiative aligns closely with the long-held principle at Clearlake that diversity drives differentiated outcomes,” said José E. Feliciano, Co-Founder and Managing Partner at Clearlake Capital. “It’s evident that the Diligent team, in tandem with the company’s industry partners, are committed to increasing diversity in leadership roles for the long-term. We are proud to partner alongside Diligent in what we hope will become a long list of our peers, as we collectively advocate and take the necessary steps to ensure a major change at the board level.”
“Insight firmly believes that diversity is a fundamental asset of high-performing boards,” said Deven Parekh, Managing Director at Insight Partners, who led the 2016 take-private of Diligent. “We’re committed to driving change within the software ecosystem and invested in Diligent because we believe its platform has potential to transform leadership. Diligent’s Director Network will enhance our board recruitment and executive search process in pursuit of better outcomes for our portfolio companies and our community. We are proud to not only participate in this initiative, but to help bring our fellow private equity peers to the boardroom table as well.”
"Grain Management was built on the principle that access is critical. The digital economy has the power to lift people up, bring people together, and level the playing field – but only if we harness technology to scale positive change. I admire how quickly the Diligent team built this new tool, to connect the supply of outstanding leaders and the demand among companies to diversify their boards,” commented David Grain, Founder and CEO of Grain Management. “I look forward to supporting this platform and benefiting from the diversity of thought, background and opinion that it helps inspire in the boards of our portfolio companies, and in companies all across the world."
Expanding the pool of diverse, board-ready candidates through partnerships with organizations whose mission is diversifying board rooms
“The Executive Leadership Council is committed to advancing the role and contributions of Black executives. This partnership with Diligent will provide our members even more visibility during the board and executive search process,” said Crystal E. Ashby, Interim President and CEO of The Executive Leadership Council. “We look forward to working together to increase the number of Black directors and executives at leading organizations.”
“There is an urgent need for more diverse board members and executives at companies around the world but change of this magnitude cannot be done alone,” said Esther Aguilera, President & CEO, Latino Corporate Directors Association. “We are excited to partner with Diligent to bring even more scale and speed to a systemic issue that is incredibly important to us and our members.”
“The Pan-Asian community is the fastest-growing population in the U.S., but approximately 70% of Fortune 1000 companies do not have the benefit of an Asian perspective in the boardroom,” stated Janet Wong, Ascend Pinnacle, Lead Executive Advisor. "Ascend is pleased to partner with Diligent to help companies tap into the broad network of talented Pan-Asian directors and executives to help ensure corporate leadership reflects their important perspectives.”
Modern Leadership is free of charge to Diligent Boards customers and designed to be inclusive of the broader community. Diligent welcomes all potential partners across diversity organizations, search firms, private equity and our clients to join in the effort to accelerate diversity in the boardroom by visiting www.diligentmodernleadership.com .
About Diligent Corporation
Diligent Corporation is the pioneer of modern governance, empowering leaders to turn effective governance into a competitive advantage. Leveraging unparalleled insights from a team of industry innovators, as well as highly secure, integrated SaaS technologies, Diligent’s industry-leading suite of solutions changes how work gets done at the executive and board levels. Leaders rely on Diligent to drive accountability and transparency, while addressing stakeholder and shareholder priorities. Its applications also help streamline the day-to-day work of board management and committees, and support collaboration and secure information sharing. Designed for both public and private sector organizations, Diligent is helping to usher in a new era of modern governance.
The largest global network of directors and executives, Diligent is relied on by more than 16,000 organizations and nearly 700,000 leaders in more than 90 countries. With an eye towards inclusivity and accessibility, Diligent serves some of the largest public governing bodies, including more than 50% of the Fortune 1000, 70% of the FTSE 100, and 65% of the ASX.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200626005236/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
